MY138266A - Treatment of neuropathy - Google Patents
Treatment of neuropathyInfo
- Publication number
- MY138266A MY138266A MYPI20024290A MY138266A MY 138266 A MY138266 A MY 138266A MY PI20024290 A MYPI20024290 A MY PI20024290A MY 138266 A MY138266 A MY 138266A
- Authority
- MY
- Malaysia
- Prior art keywords
- neuropathy
- treatment
- pregabalin
- gabapentin
- gmp
- Prior art date
Links
- 201000001119 neuropathy Diseases 0.000 title abstract 2
- 230000007823 neuropathy Effects 0.000 title abstract 2
- 208000033808 peripheral neuropathy Diseases 0.000 title abstract 2
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 abstract 2
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 abstract 1
- 229940123333 Phosphodiesterase 5 inhibitor Drugs 0.000 abstract 1
- 229960002870 gabapentin Drugs 0.000 abstract 1
- 239000002590 phosphodiesterase V inhibitor Substances 0.000 abstract 1
- 229960001233 pregabalin Drugs 0.000 abstract 1
- AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
THE PRESENT INVENTION DESCRIBES A COMBINATION COMPRISING A C-GMP PDE5 INHIBITOR WITH GABAPENTIN OR PREGABALIN, PARTICULARLY FOR THE TREATMENT OF NEUROPATHY.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9924958.3A GB9924958D0 (en) | 1999-10-21 | 1999-10-21 | Treatment of neuropathy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY138266A true MY138266A (en) | 2009-05-29 |
Family
ID=10863154
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20004933 MY127989A (en) | 1999-10-21 | 2000-10-19 | Treatment of neuropathy |
| MYPI20024290 MY138266A (en) | 1999-10-21 | 2000-10-19 | Treatment of neuropathy |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20004933 MY127989A (en) | 1999-10-21 | 2000-10-19 | Treatment of neuropathy |
Country Status (3)
| Country | Link |
|---|---|
| GB (1) | GB9924958D0 (en) |
| MY (2) | MY127989A (en) |
| NZ (1) | NZ507690A (en) |
-
1999
- 1999-10-21 GB GBGB9924958.3A patent/GB9924958D0/en not_active Ceased
-
2000
- 2000-10-19 MY MYPI20004933 patent/MY127989A/en unknown
- 2000-10-19 MY MYPI20024290 patent/MY138266A/en unknown
- 2000-10-20 NZ NZ50769000A patent/NZ507690A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ507690A (en) | 2002-10-25 |
| MY127989A (en) | 2007-01-31 |
| GB9924958D0 (en) | 1999-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU0004120D0 (en) | ||
| WO2002074293A3 (en) | Methods for restoring cognitive function following systemic stress | |
| MY135233A (en) | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials | |
| EP3738591A3 (en) | Novel antibacterial agents | |
| MXPA03010327A (en) | Use of osteopontin for the treatment and/or prevention of neurologic diseases. | |
| PL324330A1 (en) | Do- and trivalent low-molecule selectin inhibitors | |
| ZA996622B (en) | Treatment of BPH with cGMP elevators. | |
| MXPA03002861A (en) | Retinoids for the treatment of emphysema. | |
| AU148078S (en) | Bottle | |
| EP1262556A3 (en) | Antimicrobial peptides and method for identifying and using such peptides | |
| ZA200200031B (en) | Safety catch for pistols. | |
| WO2001078654A3 (en) | Halogentated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors | |
| CA98129S (en) | Storage case | |
| NZ320259A (en) | Deodorizing preparations containing cationic biopolymers, aluminium hydrochlorate and esterase inhibitors | |
| AU148415S (en) | Bottle | |
| MY138266A (en) | Treatment of neuropathy | |
| MXPA04000008A (en) | Carbamates of 2-heterocyclic-1,2-ethanediols. | |
| AU7919698A (en) | Formic acid solution with reduced corrosive effect | |
| WO2003014156A3 (en) | NEUREGULIN-β ISOFORMS ASSOCIATED WITH NEURONAL PROCESSES | |
| AU2001256406A1 (en) | Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity | |
| IL144667A0 (en) | New assay | |
| WO2004006866A3 (en) | Antifungal therapeutic targets | |
| WO1999066609A3 (en) | Light source with a cavity including a gas | |
| GB0111551D0 (en) | F.R.at source | |
| ZA200205460B (en) | A light source. |